Human CXCL10/IP-10 PicoKine ELISA Kit standard curve
Human CXCL10/IP-10 PicoKine ELISA Kit standard curve
Human CXCL10/IP-10 ELISA Kit PicoKine(r)
EK0735
Product group Assays
Overview
- SupplierBoster Bio
- Product NameHuman CXCL10/IP-10 PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range31.2 pg/ml - 2,000 pg/ml
- Assay Sensitivity<1 pg/ml
- Assay Time20-25
- CertificationResearch Use Only
- Scientific DescriptionHuman CXCL10/IP-10 ELISA Kit PicoKine® (96 Tests). Quantitate Human CXCL10 in cell culture supernatants, serum, plasma (heparin, EDTA) , saliva and urine. Sensitivity: 1pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierHuman CXCL10
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Lv Y, Yang Z, Hai L, et al. Differential alterations of CXCR3, CXCR5 and CX3CR1 in patients with immune thrombocytopenia. Cytokine. 2024,181:156684. doi: 10.1016/j.cyto.2024.156684Read this paper
- Cai X, Yu X, Tang T, et al. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. Mol Carcinog. 2024,63(9):1682-1696. doi: 10.1002/mc.23753Read this paper
- Hoffmann JA, Gründler K, Richter DU, et al. Prediction of spontaneous preterm birth using CCL2 and CXCL10 in maternal serum of symptomatic high-risk pregnant women: a prospective cohort study. BMC Pregnancy Childbirth. 2023,23(1):697. doi: 10.1186/s12884-023-06016-3Read this paper
- Chen Y, Wang Y, Xu J, et al. Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury. Inflammation. 2023,46(1):244-255. doi: 10.1007/s10753-022-01729-7Read this paper
- Farcomeni S, Moretti S, Fimiani C, et al. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens. 2021,10(11). doi: 10.3390/pathogens10111488Read this paper
- Aslan FG, Koroglu M, Karabay O, et al. A Predictive Test in The Screening of HIV Positive Cases; Interferon Gamma Inducible Protein 10 (IP-10). Clin Lab. 2021,67(4). doi: 10.7754/Clin.Lab.2020.190611Read this paper
- Peeridogaheh H, Pourhajibagher M, Barikani HR, et al. The impact of Aggregatibacter actinomycetemcomitans biofilm-derived effectors following antimicrobial photodynamic therapy on cytokine production in human gingival fibroblasts. Photodiagnosis Photodyn Ther. 2019,27:1-6. doi: 10.1016/j.pdpdt.2019.05.025Read this paper
- Wang H, Li J, Zhong P, et al. Blocking CXCR3 with AMG487 ameliorates the blood-retinal barrier disruption in diabetic mice through anti-oxidative. Life Sci. 2019,228:198-207. doi: 10.1016/j.lfs.2019.04.016Read this paper
- Lu Y, Lin LY, Tan JG, et al. A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis. Eur Rev Med Pharmacol Sci. 2017,21(6):1290-1295.Read this paper
- Wang BF, Cao PP, Long XB, et al. Distinct mucosal immunopathologic profiles in atopic and nonatopic chronic rhinosinusitis without nasal polyps in Central China. Int Forum Allergy Rhinol. 2016,6(10):1013-1019. doi: 10.1002/alr.21799Read this paper
